BioMarin今年新任首席数字信息官Arpit Davé表示,其职业核心是用技术与数据(包括AI)帮助企业履行服务患者的使命。他认为技术近年才真正跟上愿景,如今是把科学承诺转化为健康改善的时机。他计划将公司三十年科学专长与新兴技术结合,加速惠及罕见遗传病患者。
For much of his career, Arpit Davé has been fascinated by an idea: Some of the biggest opportunities in biopharma lie not in the science alone, but in how organizations can most effectively learn from the vast amounts of data that science generates.
Long before today's excitement around AI, Arpit saw the potential for technology to help researchers uncover new insights, connect information and make better decisions. The challenge was that the ambition often outpaced the tools available to support it. But in recent years, he says, technology has caught up enough to turn potential into reality.
"My career journey has really been about cracking this complex problem of using technology and data, and now this powerful tool of AI, to allow companies to fulfill their mission, which is to serve patients,” Arpit says. “There has never been a time like the present for using technology to deliver on the promise of science to improve human health – now it’s on us to seize the moment.”
We recently sat down with Arpit, who joined BioMarin earlier this year as Chief Digital Information Officer, to discuss his career journey, what brought him here and how he envisions combining the company’s three decades of scientific expertise with emerging technology to accelerate impact for people with rare genetic conditions.
Read more: http://ms.spr.ly/6014avOgM
来源:BioMarin · x.com